News and Press Releases
Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy
BOSTON, Aug. 14, 2025 -- Tiziana Life Sciences, Ltd (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human,...
Category: Clinical Trials
Posted: August 14, 2025
Tiziana Life Sciences 14/15 Conduit Street London W1S 2XJ United Kingdom
Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease
Paris, August 14, 2025: The European Medicines Agency has granted orphan designation to rilzabrutinib, a reversible covalent Bruton’s tyrosine kinase (BTK) inhibitor, for IgG4-related disease (IgG4-RD). EMA grants orphan designation...
Category: Clinical Trials
Posted: August 14, 2025
BIO-Europe 2025
10 July 2025 -- Vienna, Austria -- BIO-Europe, Europe's premier biopharma partnering event, is heading to Vienna, Austria on November 3-5, 2025, followed by Digital Partnering on November 11-12. Drawing...
Category: BioManufacturing, Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: July 10, 2025
BIO-Europe® 2025 Gathers Global Life Sciences Leaders in Vienna
2 July 2025 -- Munich, Germany -- The 31st annual edition of BIO-Europe, the premier partnering conference for the global biopharmaceutical industry, will take place in Vienna, Austria, from November...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: July 2, 2025
Iksuda Therapeutics receives FDA IND clearance for IKS014
FDA decision will enable Iksuda to expand its ongoing clinical trial in the US, Australia and Singapore Preliminary data from an ongoing dose-escalation study of IKS014 has shown meaningful clinical activity across...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: July 1, 2025
Healthcare Finance and Smart Materials Experts Delivering Opening and Closing Plenaries at PharmSci 360
26 June 2025 -- Virginia, US -- AAPS is excited to announce the opening and closing plenary speakers for the 2025 PharmSci 360, taking place November 9-12, in San Antonio,...
Category: Biotechnology, Drug Delivery, Logistics, Other, Pharmaceutical
Posted: June 26, 2025
2107 Wilson Blvd #200 Arlington, VA 22201
Oxeltis and academic partners receive grant funding worth nearly €800,000 to develop antiviral for Bunyaviricetes
France’s National Research Agency (ANR) and Defense Innovation Agency (AID) will finance BUNYANTIVIR project to introduce novel therapeutic approach for Bunyaviricetes class of human pathogenic viruses found in tropical and...
Category:
Posted: June 25, 2025
Novo Nordisk A/S: Ozempic receives EU recommendation in peripheral arterial disease, cementing the broad benefits of semaglutide for people with type 2 diabetes and comorbidities
Pending a decision from the European Commission, Ozempic (once-weekly semaglutide) will have the broadest approved label in the glucagon-like peptide-1 receptor agonist (GLP-1 RA) class, demonstrating improvements in blood sugar,...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: June 23, 2025
Kite’s CAR T-Cell Therapy Data Show Real-World Patient Benefit and Durable Response Across Difficult-to-Treat Blood Cancers
Largest Real-World (RW) Analyses of Yescarta® (Axicabtagene Ciloleucel) Show 74% Overall Survival (OS) at 12 Months in Second-Line Relapsed/Refractory Large B-cell Lymphoma (LBCL), Consistent with OS Reported in Pivotal ZUMA-7 Study,...
Category: Biotechnology, Clinical Trials, Drug Delivery, Drug Discovery, Other, Pharmaceutical
Posted: June 12, 2025
At BIO Show in Boston, PCI Pharma Services to Provide Updates on New Manufacturing Facility at Nearby Bedford, NH Campus
For leading CDMO, qualification activities for plant’s state-of-the-art sterile fill-finish and lyophilization line are underway, with GMP production commencing summer 2025 6 June 2025 -- Pennsylvania, US -- PCI Pharma Services, a world...
Category: BioManufacturing, Logistics, Manufacturing and Packing, Other, Pharmaceutical
Posted: June 6, 2025
Curated, Collaborative, Connected: Why LogiPharma 2025 Is Being Called the Industry’s Best Yet
6 June 2025 -- Lyon, France -- Following a landmark gathering of over 2,200 life sciences supply chain leaders in April, LogiPharma’s 25th anniversary edition is being recognised not only...
Category: Logistics, Other, Pharmaceutical
Posted: June 6, 2025
Two Weeks to Go – London Biotechnology Show 2025 Gears Up to Spotlight Industry Pioneers, Disruptive Tech, Emerging Innovators
2 June 2025 -- London, UK -- In just two weeks, the second edition of the London Biotechnology Show (LBS) returns to ExCeL London on 18–19 June, bringing together one...
Category: BioManufacturing, Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: June 2, 2025
Chemspec Europe 2025 opens next week: Europe’s top event for fine and speciality chemicals set for strongest edition to date
30 May 2025 -- Koelnmesse, Germany -- From 4–5 June, thousands of industry professionals will gather in Cologne for the 38th edition of Chemspec Europe – the leading marketplace for fine...
Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: May 30, 2025
Enhancing Clinical Trials for Faster, More Predictable Outcomes with WCG Study Accelerator
May 28, 2025 – CARY, NC – WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, today announced the launch of WCG Study Accelerator, an...
Category: Clinical Trials
Posted: May 29, 2025
Attend Europe’s leading vaccine event!
World Vaccine Congress Europe will host 2500+ attendees, 280 speakers, 150 exhibitors and start-ups over the course of 4 days. With a multitude of tracks, the congress will cover everything...
Category: Biotechnology, Other, Pharmaceutical
Posted: May 27, 2025
